DK1135401T3 - Glycerylnucleotider, fremgangsmåder til deres fremstilling og deres anvendelse - Google Patents
Glycerylnucleotider, fremgangsmåder til deres fremstilling og deres anvendelseInfo
- Publication number
- DK1135401T3 DK1135401T3 DK99958161T DK99958161T DK1135401T3 DK 1135401 T3 DK1135401 T3 DK 1135401T3 DK 99958161 T DK99958161 T DK 99958161T DK 99958161 T DK99958161 T DK 99958161T DK 1135401 T3 DK1135401 T3 DK 1135401T3
- Authority
- DK
- Denmark
- Prior art keywords
- radicals
- nucleoside
- compounds
- processes
- group
- Prior art date
Links
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 title abstract 2
- 150000003254 radicals Chemical class 0.000 abstract 5
- 125000003835 nucleoside group Chemical group 0.000 abstract 4
- -1 polyoxyalkenyl Chemical group 0.000 abstract 4
- 150000001875 compounds Chemical class 0.000 abstract 3
- 125000003342 alkenyl group Chemical group 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 208000035473 Communicable disease Diseases 0.000 abstract 1
- 101100406515 Drosophila melanogaster orb2 gene Proteins 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 101100258025 Schizosaccharomyces pombe (strain 972 / ATCC 24843) shk1 gene Proteins 0.000 abstract 1
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 125000004423 acyloxy group Chemical group 0.000 abstract 1
- 125000005035 acylthio group Chemical group 0.000 abstract 1
- 125000003302 alkenyloxy group Chemical group 0.000 abstract 1
- 125000005108 alkenylthio group Chemical group 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000004414 alkyl thio group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 150000005840 aryl radicals Chemical class 0.000 abstract 1
- 125000005110 aryl thio group Chemical group 0.000 abstract 1
- 125000004104 aryloxy group Chemical group 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- PXQLVRUNWNTZOS-UHFFFAOYSA-N sulfanyl Chemical class [SH] PXQLVRUNWNTZOS-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
- C07H19/207—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids the phosphoric or polyphosphoric acids being esterified by a further hydroxylic compound, e.g. flavine adenine dinucleotide or nicotinamide-adenine dinucleotide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- Genetics & Genomics (AREA)
- Communicable Diseases (AREA)
- Hematology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19855963A DE19855963A1 (de) | 1998-12-04 | 1998-12-04 | Amphiphile Glycerylnucleotide, Verfahren zu ihrer Herstellung und ihre Verwendung |
| PCT/EP1999/009461 WO2000034298A1 (de) | 1998-12-04 | 1999-12-03 | Glycerylnucleotide, verfahren zu ihrer herstellung und ihre verwendung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1135401T3 true DK1135401T3 (da) | 2003-10-06 |
Family
ID=7889957
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK99958161T DK1135401T3 (da) | 1998-12-04 | 1999-12-03 | Glycerylnucleotider, fremgangsmåder til deres fremstilling og deres anvendelse |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US6787525B1 (enExample) |
| EP (1) | EP1135401B1 (enExample) |
| JP (1) | JP4879398B2 (enExample) |
| AT (1) | ATE243220T1 (enExample) |
| AU (1) | AU1558800A (enExample) |
| CA (1) | CA2352229C (enExample) |
| DE (2) | DE19855963A1 (enExample) |
| DK (1) | DK1135401T3 (enExample) |
| ES (1) | ES2201805T3 (enExample) |
| WO (1) | WO2000034298A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10228059B4 (de) * | 2002-06-19 | 2005-12-29 | Eberhard-Karls-Universität Tübingen | Verwendung von amphiphilen Nucleosid-Phosphonoameisensäure-Derivaten zur Behandlung von viralen Infektionskrankheiten |
| US7593913B2 (en) * | 2006-01-11 | 2009-09-22 | Siemens Medical Solutions Usa, Inc. | Systems and method for integrative medical decision support |
| CA2812962C (en) | 2010-09-22 | 2020-03-31 | Alios Biopharma, Inc. | Azido nucleosides and nucleotide analogs |
| EP2794627B1 (en) | 2011-12-22 | 2018-09-26 | Alios Biopharma, Inc. | Substituted nucleosides, nucleotides and analogs thereof |
| US9441007B2 (en) | 2012-03-21 | 2016-09-13 | Alios Biopharma, Inc. | Substituted nucleosides, nucleotides and analogs thereof |
| USRE48171E1 (en) | 2012-03-21 | 2020-08-25 | Janssen Biopharma, Inc. | Substituted nucleosides, nucleotides and analogs thereof |
| HUE029038T2 (en) | 2012-05-25 | 2017-01-30 | Janssen Sciences Ireland Uc | Uracil spirooxetan nucleosides |
| EP2935303B1 (en) | 2012-12-21 | 2021-02-17 | Janssen BioPharma, Inc. | 4'-fluoro-nucleosides, 4'-fluoro-nucleotides and analogs thereof for the treatment of hcv |
| AU2014331863C1 (en) | 2013-10-11 | 2019-05-16 | Alios Biopharma, Inc. | Substituted nucleosides, nucleotides and analogs thereof |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH03236396A (ja) * | 1990-02-10 | 1991-10-22 | Tosoh Corp | 修飾オリゴデオキシヌクレオチド及びそれを含むｄｎａ |
| JPH0421694A (ja) * | 1990-05-16 | 1992-01-24 | Asahi Chem Ind Co Ltd | 新規なヌクレオシド―リン脂質複合体 |
| DE69119074T2 (de) * | 1990-06-15 | 1996-12-12 | University Of North Carolina At Chapel Hill, Chapel Hill, N.C. | Kovalente-ther lipidnukleosid-konjugate |
| CA2129986C (en) | 1992-02-13 | 2003-12-09 | Albert Reto Schwendener | Amphiphile nucleosidphosphatanaloga |
| DE4418690A1 (de) * | 1994-05-28 | 1996-01-11 | Boehringer Mannheim Gmbh | Neue Lipidester von Nucleosid-Monophosphaten und deren Verwendung als immunsuppressive Arzneimittel |
| DE69535758D1 (de) * | 1994-08-29 | 2008-07-03 | Univ Wake Forest | Lipid-analoge zur behandlung von viralen infektionen |
| AU3120797A (en) | 1996-05-08 | 1998-07-31 | Weider Nutrition Group, Inc. | Structured glycerols and structured phosphatides |
| US6686462B2 (en) * | 1997-02-28 | 2004-02-03 | The Regents Of The University Of California | Antiviral compounds and methods of administration |
-
1998
- 1998-12-04 DE DE19855963A patent/DE19855963A1/de not_active Withdrawn
-
1999
- 1999-12-03 DE DE59906041T patent/DE59906041D1/de not_active Expired - Lifetime
- 1999-12-03 AT AT99958161T patent/ATE243220T1/de not_active IP Right Cessation
- 1999-12-03 AU AU15588/00A patent/AU1558800A/en not_active Abandoned
- 1999-12-03 DK DK99958161T patent/DK1135401T3/da active
- 1999-12-03 EP EP99958161A patent/EP1135401B1/de not_active Expired - Lifetime
- 1999-12-03 WO PCT/EP1999/009461 patent/WO2000034298A1/de not_active Ceased
- 1999-12-03 JP JP2000586741A patent/JP4879398B2/ja not_active Expired - Fee Related
- 1999-12-03 CA CA002352229A patent/CA2352229C/en not_active Expired - Fee Related
- 1999-12-03 US US09/856,165 patent/US6787525B1/en not_active Expired - Fee Related
- 1999-12-03 ES ES99958161T patent/ES2201805T3/es not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| AU1558800A (en) | 2000-06-26 |
| JP4879398B2 (ja) | 2012-02-22 |
| ATE243220T1 (de) | 2003-07-15 |
| DE59906041D1 (de) | 2003-07-24 |
| CA2352229A1 (en) | 2000-06-15 |
| JP2002531573A (ja) | 2002-09-24 |
| US6787525B1 (en) | 2004-09-07 |
| EP1135401B1 (de) | 2003-06-18 |
| WO2000034298A1 (de) | 2000-06-15 |
| DE19855963A1 (de) | 2000-06-08 |
| EP1135401A1 (de) | 2001-09-26 |
| ES2201805T3 (es) | 2004-03-16 |
| CA2352229C (en) | 2009-06-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0481214T3 (da) | Prolægemidler af phosphonater | |
| DK1914237T3 (da) | Antivirale fosfonatesterforbindelser | |
| CY1121639T1 (el) | Συνθεσεις που περιλαμβανουν προφαρμακα νουκλεοτιδιων και ολιγονουκλεοτιδιων | |
| UY28084A1 (es) | Derivados antivirales de nucleosidos | |
| AR021844A1 (es) | Derivados de propanolamina aril-sustituidos, procedimientos para su preparacion, medicamentos que contienen estos compuestos y su utilizacion | |
| KR920002625A (ko) | 말단에 3'-3' 또는 5'-5' 뉴클레오타이드간 결합을 갖는 올리고뉴클레오타이드 유사체 | |
| PT971888E (pt) | Compostos de 2-alquil-19-nor-vitamina d | |
| EP1201678A4 (en) | BICYCLONUCLEOSID Analogs | |
| NO940804D0 (no) | Imidazolidylmakrolider | |
| NO20073257L (no) | 18-methyl-19-nor-17-pregn-4-en-21,17-carbolactones and pharmaceutical preparations comprising the same | |
| DK1135401T3 (da) | Glycerylnucleotider, fremgangsmåder til deres fremstilling og deres anvendelse | |
| BR9708114A (pt) | Análogos xantona para o tratamento de doenças infecciosas. | |
| FR2374334A1 (fr) | Nouveaux nucleosides utiles comme medicaments et procede pour leur preparation | |
| ES2101026T3 (es) | Derivados sulfatados de glicosaminoglicanoides. | |
| ES2131972T3 (es) | Derivados de sulfamato de derivados del 1,3,5(10)-estratrieno, procedimiento para su fabricacion y composiciones farmaceuticas que contienen estos compuestos. | |
| PT77991A (en) | Process for the preparation of benzoylurea compounds and pesticidal and pharmaceutical compositions comprising same and for their utilization in the control of insects and/or acarids and for combating tumors in living beings respectively | |
| NO20014241D0 (no) | C16-umettede FP-selektive prostaglandinanaloger | |
| BRPI0417988A (pt) | análogos de fosfonato antivirais | |
| ATE346036T1 (de) | Antiangiogene substanz zur behandlung von krebs, arthritis und netzhauterkrankungen | |
| KR910016751A (ko) | 치환된 푸린, 이의 제조방법 및 항비루스제로서의 이의 용도 | |
| FR2765222B1 (fr) | Nouveaux composes de n-benzenesulfonyl-l-proline, procede de preparation et utilisation en therapeutique | |
| ES2150107T3 (es) | Inmunogenos no toxicos que proceden de una proteina de regulacion retroviral, anticuerpos dirigidos contra estos inmunogenos, procedimiento para su preparacion y composiciones farmaceuticas que los contienen. | |
| RU2005128830A (ru) | Обладающие противоопухолевым действием 2-замещенные d-гомоэстра-1, 3, 5( 10 )-триен-3-илсульфаматы | |
| AU668506B2 (en) | Targeted drug delivery via mixed phosphate derivatives | |
| EE200200302A (et) | Küllastumata 14,15-tsüklopropanoandrostaanid, nende valmistamise meetod ja neid ühendeid sisaldavadfarmatseutilised kompositsioonid |